FeesSafety
Pluang+

Foghorn Therapeutics to present at three major healthcare investor conferences in November 2026

Market News
03 Nov 2026, 14:00 WIB
GlobeNewsWire
View Source
Neutral
Foghorn Therapeutics to present at three major healthcare investor conferences in November 2026

Foghorn Therapeutics announced that its management, led by CEO Adrian Gottschalk, will participate in three upcoming investor conferences in November 2026: the Guggenheim Healthcare Innovation Conference, the Stifel Healthcare Conference, and the Jefferies London Healthcare Conference. The company will present in fireside chats and one-on-one meetings, highlighting its progress in developing novel medicines for oncology and immunology. These events provide Foghorn an opportunity to engage with investors and showcase its pipeline advancements and strategic focus.

Foghorn Therapeutics' upcoming investor conference participation is presented here with a snapshot of the Health sector on Pluang as of Nov 03, 2026 19:02 WIB. Of 150 priced Health-sector US stocks, 74 rose and 69 fell today. Among notable movers, NBIX rose 6.01% to USD 154.08 with a 100% sell order activity and a typical hold time of 28 days, contrasting with INO which dropped 5.56% to USD 1.78 and showed a nearly balanced buy-sell order split. PHG also gained 5.94% to USD 29.23 with a longer typical hold time of 86 days.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App